HomeXFOR • NASDAQ
add
X4 Pharmaceuticals Inc
Previous close
$0.21
Day range
$0.20 - $0.23
Year range
$0.19 - $1.39
Market cap
35.57M USD
Avg Volume
1.78M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
MarketWatch
14 hours ago
S&P 500 tallies its first ‘death cross’ in 3 years. Here’s what happens next.
0.79%
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 1.43M | — |
Operating expense | 36.85M | 46.22% |
Net income | -39.82M | -108.16% |
Net profit margin | -2.78K | — |
Earnings per share | -0.20 | -100.00% |
EBITDA | -35.44M | -41.00% |
Effective tax rate | -0.65% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 102.06M | -10.64% |
Total assets | 146.45M | -0.55% |
Total liabilities | 124.30M | 29.26% |
Total equity | 22.15M | — |
Shares outstanding | 173.66M | — |
Price to book | 1.62 | — |
Return on assets | -55.01% | — |
Return on capital | -75.01% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -39.82M | -108.16% |
Cash from operations | -33.00M | -18.91% |
Cash from investing | -8.62M | -78.38% |
Cash from financing | 135.00K | 39.18% |
Net change in cash | -41.72M | -28.96% |
Free cash flow | -19.64M | -7.11% |
About
Founded
Mar 13, 2019
Headquarters
Website
Employees
143
